Today: 7 February 2026
Subscribe
Browse Category

Investment Forecasts News 3 December 2025 - 8 December 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc. (NASDAQ: CAN), the Bitcoin mining hardware maker turned vertically integrated miner, is back in the spotlight on December 8, 2025 after BTIG launched coverage with a Buy rating and a $3.00 price target, implying several hundred percent upside from where the stock trades today. Investing.com+1 At the same time, Canaan’s fundamentals have sharply improved, its energy strategy is getting greener, and Wall Street’s published forecasts for 2025–2026 are aggressively bullish — even as many quantitative and technical models remain cautious. Here’s a detailed look at where CAN stands right now for readers following the stock on Google News
8 December 2025
····
Genting Singapore (SGX:G13) on 8 December 2025: Share Price, Q3 2025 Results, RWS 2.0 Expansion and 2026 Forecasts

Genting Singapore (SGX:G13) on 8 December 2025: Share Price, Q3 2025 Results, RWS 2.0 Expansion and 2026 Forecasts

Genting Singapore Limited, the operator of Resorts World Sentosa (RWS) and a heavyweight on the Straits Times Index, is in an interesting spot on 8 December 2025: fundamentals and tourism recovery are improving, yet the share price is still treading water near the lower end of analyst target ranges.Beansprout+2The Business Times+2 This article rounds up the latest news, forecasts and analyses on Genting Singapore stock as of 8 December 2025, with a focus on what matters for investors tracking SGX:G13. Genting Singapore share price today (8 December 2025) As at around 09:20 SGT on 8 December 2025, Genting Singapore shares
8 December 2025
····
Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group N.V. (NASDAQ: NBIS) has quickly become one of the most talked‑about names in the AI infrastructure “neocloud” trade. As of December 6, 2025, the stock is well off its October peak but still massively ahead of where it started the year, with investors trying to decide whether the latest pullback is a buying opportunity or a warning sign. At Friday’s close (December 5), Nebius traded around $98 per share, down about 4.6% on the day and roughly 30% below its 52‑week high of $141.10, yet still more than 435% above its 52‑week low near $18 in April. StockAnalysis+1
6 December 2025
·····
National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank Limited (ASX:NAB) shares are trading around A$40.6–A$40.7 on Friday, 5 December 2025, nudging higher after a volatile November as investors weigh a solid dividend stream against slower profit growth and a richer valuation multiple. StockAnalysis+1 According to live market data, NAB was recently quoted at A$40.64, up about 0.3–0.4% on the day, with an intraday range of A$40.28 to A$40.77 and a 52‑week range of A$31.13 to A$45.25. StockAnalysis+1 On a trailing 12‑month basis, the bank has generated roughly 14% year‑to‑date and about 9% one‑year total return including dividends, based on Yahoo Finance figures. Yahoo Finance At
5 December 2025
···
Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Updated December 5, 2025 – all developments since December 4, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has moved back into the market spotlight after a flurry of major announcements on December 4, 2025. The biotech’s stock — already one of 2025’s wildest movers — is reacting to fresh positive data in rare epilepsies and new regulatory momentum for its lead essential tremor drug. Below is a structured rundown of what has happened since December 4, 2025, how analysts now value PRAX stock, and what investors are watching into 2026. This article is for information only and is not financial
5 December 2025
····
Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of 2025’s wildest stories in quantum computing and in the broader U.S. stock market. After rocketing from penny‑stock territory in 2023 to a 2025 high above $58, the stock has just endured a brutal November sell‑off tied to Q3 2025 earnings, even as the company doubles down on an aggressive roadmap toward 1,000+ qubits and deep partnerships with NVIDIA, global research labs, and defense customers. StockScan+1 As of December 4, 2025, Rigetti shares trade around $28 per share, well below their October peak but still hundreds of percent higher than a year ago.
4 December 2025
····
Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s Nasdaq listing alive. SEC+1 As of the U.S. session on 4 December 2025, IXHL was trading around $0.48 per share, up roughly 8% on the day and extending a sharp two-day rebound following the Fast Track news. ChartMill Below is
4 December 2025
·····
Robinhood Stock (HOOD) Jumps on Crypto Rebound: Latest News, Earnings Beat and 2026 Forecast – 4 December 2025

Robinhood Stock (HOOD) Jumps on Crypto Rebound: Latest News, Earnings Beat and 2026 Forecast – 4 December 2025

Robinhood Markets, Inc. (NASDAQ: HOOD) is back in the spotlight. On Thursday, 4 December 2025, HOOD is trading around $133–134 per share, up roughly 6% on the day, after another crypto‑driven surge in trading activity. That puts Robinhood’s market value near $120 billion and leaves the stock only about 13–18% below its October all‑time high, while still hundreds of percent above its spring lows. MarketBeat+1 After a year defined by parabolic gains, explosive earnings growth and aggressive product expansion, investors are now trying to decide whether HOOD is still a buy — or already priced for perfection. Here’s a detailed,
4 December 2025
····
Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Updated: December 4, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) is back in the market spotlight. The AI‑focused chip designer has just delivered record quarterly results, unveiled a $3.25 billion acquisition of photonics startup Celestial AI, and triggered a wave of bullish analyst upgrades. As of midday on December 4, 2025, Marvell shares are trading around $100 per share, up roughly 8% on the day and about 16% above where they closed before the earnings and deal announcement, pushing the company’s market value to about $86 billion. trendspider.com+1 Below is a detailed look at what changed for Marvell this week, how
4 December 2025
·····
Pro Medicus (ASX: PME) Share Price Update: Data Breach Explained, New US Contracts and 2026 Stock Forecast

Pro Medicus (ASX: PME) Share Price Update: Data Breach Explained, New US Contracts and 2026 Stock Forecast

Published: 4 December 2025 Pro Medicus share price today Pro Medicus Limited (ASX: PME), the $27‑billion Australian healthcare imaging software group, is trading around A$253–255 per share in Thursday trade, slightly lower on the session after the company confirmed details of an isolated cybersecurity incident.Investing.com Nigeria+1 Over the past 12 months, PME has traded between roughly A$162 and A$336, with the July 2025 peak marking an all‑time high and the April low coming after a broader tech sell‑off.Investing.com Nigeria+1 Despite the pull‑back from those highs, the stock remains well above its early‑2024 levels and still prices in substantial growth. Today’s
4 December 2025
····
CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced thousands of job cuts, delayed a major spin‑off, launched a A$750 million buy‑back and opened a A$1 billion cell‑based vaccine and antivenom plant in Melbourne – all while its share price has fallen by roughly a third. Intelligent Investor+2Global Newsroom | CSL+2 Against that backdrop, investors are trying to decide whether CSL is now a long‑term bargain or a restructuring
4 December 2025
····
Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (NYSE: APH) remains one of the standout performers in large-cap technology hardware as of December 3, 2025, powered by the AI datacenter boom, aggressive M&A and strong institutional demand – but also carrying a valuation that many analysts now describe as “stretched.” Below is a detailed look at where Amphenol stock stands today, the most important news and filings around December 3, 2025, and how Wall Street forecasts and valuations stack up heading into 2026. APH stock today: price, performance and basic stats As of the latest quote on December 3, 2025, Amphenol Corporation stock trades around $139–140
3 December 2025
·····
1 2 3 4

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop